White Paper:

Screen Shot 2020-09-15 at 10.38.44 AM-1

Using the latest FAERS data, Advera Health reviewed the top 6 most widely used COVID-19 treatments for potential safety signals:

  • remdesivir (Veklury (Gilead Sciences)
  • azithromycin (Zithromax (Pfizer/Generic)
  • hydroxychloroquine (Plaquenil (Advanz Pharma, Generic)
  • lopinavir/ritonavir (Kaletra (Abbvie)
  • sarilumab (Kevzara (Sanofi, Regeneron)
  • tocilizumab (Actemra (Roche)).

The report includes new potential safety signals, dechallenge and rechallenge data, detailed signal analysis and ROR forest plots, and top 10 highest reported adverse event tables for each product. 

 

 

DOWNLOAD NOW:

Evidex Signal Management

A next generation pharmacovigilance workflow platform that allows an organization to track and resolve safety signals and inquiries.
face.png

Best-in-Class UX/UI

Built within the Evidex framework, Evidex Signal Management provides audit ready tools that safety reviewers want to use
gears.png

Automation Made Easy

Fully integrated and automated signal detection from multiple data sources, powered by Evidex Data & Analytics provides a wholistic, modern approach to pharmacovigilance
paper.png

Validated Off-the-Shelf

Validated off-the-shelf configuration based on GVP Module IX offers fast, compliant, and lean implementation, while maintaining the flexibility to meet any organization's unique needs

See Pharmacovigilance 2.0 for yourself.

Request a Demonstration Now!
SIGN UP FOR FREE TRIAL
© 2023 Advera Health Analytics, Inc.